Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2026-04-25 @ 9:41 PM
Study NCT ID:
NCT05282420
Status:
UNKNOWN
Last Update Posted:
2022-03-16
First Post:
2022-03-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ranibizumab Versus Aflibercept for CRVO in Young Patients.
Sponsor:
South Valley University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-Ischemic Central Retinal Vein Occlusion With Macular Edema | View |